Abbott Medical Devices Trading (Shanghai) Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Af Ablation In Brady-Tachy Syndrome

Not Applicable

Terminated

Conditions: Brady-tachy Syndrome

Interventions: Procedure: AF ablation + pacemaker implantation
Procedure: Pacemaker implantation

First Posted Date: 2008-08-22

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 38

Registration Number: NCT00740272

Locations: 🇫🇷
Hôpital St joseph, Marseille, France
🇫🇷
CHU, Rouen, France
🇫🇷
Clinique Pasteur, Toulouse, France

A(f)MAZE-CABG Study

Not Applicable

Terminated

Conditions: Coronary Arteriosclerosis
Atrial Fibrillation
Coronary Artery Bypass Graft Surgery

Interventions: Device: HIFU AF Ablation

First Posted Date: 2008-08-15

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 188

Registration Number: NCT00735722

Locations: 🇩🇪
Herzzentrum Essen, Essen, North Rhine-Westphalia, Germany
🇩🇪
Universitatsklinikum Schleswig Holstein Campus Luebeck, Luebeck, Schleswig-Holstein, Germany
🇬🇧
Derriford Hospital, Plymouth, Devon, United Kingdom

and more 7 locations

RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System

Completed

Conditions: Peripheral Vascular Disease
Cardiovascular Disease

Interventions: Device: Vessel Closure (StarClose™)

First Posted Date: 2008-08-15

Last Posted Date: 2008-08-15

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 165

Registration Number: NCT00736086

Locations: 🇺🇸
Heart Care Midwest (OSF/St Francis), Peoria, Illinois, United States
🇺🇸
Bay Regional Medical Center, Bay City, Michigan, United States
🇺🇸
St. Luke's Hospital, Kansas City, Missouri, United States

and more 8 locations

XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery

Completed

Conditions: Atherosclerosis
Coronary Artery Disease

First Posted Date: 2008-08-08

Last Posted Date: 2009-10-16

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 2517

Registration Number: NCT00731237

Locations: 🇺🇸
NEA Baptist Memorial Hospital, Jonesboro, Arkansas, United States
🇺🇸
University Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States
🇺🇸
Palmetto Health Clinic, Columbia, South Carolina, United States

and more 40 locations

An Observational, Prospective Evaluation of the Trifecta™ Valve

Not Applicable

Completed

Conditions: Regurgitation, Aortic Valve
Aortic Valve Incompetence
Aortic Valve Insufficiency
Aortic Valve Stenosis

Interventions: Device: Trifecta aortic heart valve

First Posted Date: 2008-08-01

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 120

Registration Number: NCT00727181

Locations: 🇳🇱
Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
🇫🇷
Hôpital de Pontchaillou, Rennes, France
🇩🇪
Universitat Herzzentrum Leipzig GmbH, Leipzig, Germany

and more 1 locations

Multicenter International Trial Ring AnnulopLasty

Not Applicable

Completed

Conditions: Mitral Valve Insufficiency

Interventions: Device: mitral valve repair (SJM® Rigid Saddle Ring)

First Posted Date: 2008-08-01

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 180

Registration Number: NCT00727012

Locations: 🇩🇪
University of Heidelberg, Heidelberg, Germany

AMPLATZER Duct Occluder II Clinical Study

Not Applicable

Completed

Conditions: Patent Ductus Arteriosus

Interventions: Device: AMPLATZER Duct Occluder II

First Posted Date: 2008-07-11

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 192

Registration Number: NCT00713700

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
🇺🇸
Alfred I. DuPont Hospital for Children -Nemours Cardiac Center, Wilmington, Delaware, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

and more 22 locations

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)

Completed

Conditions: Coronary Artery Disease

Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent

First Posted Date: 2008-05-13

Last Posted Date: 2012-11-20

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 8053

Registration Number: NCT00676520

Locations: 🇺🇸
Abbott Vascular, Santa Clara, California, United States

Atrial Fibrillation Management in Congestive Heart Failure With Ablation

Not Applicable

Completed

Conditions: ICD
Persistent Atrial Fibrillation
Heart Failure

Interventions: Device: ICD/CRT implant
Other: Best Medical Treatment
Procedure: AF ablation

First Posted Date: 2008-04-03

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 202

Registration Number: NCT00652522

Locations: 🇩🇪
Herz- und Gefaesszentrum Bad Bevensen, Bad Bevensen, Germany
🇩🇪
Universitäts-Herzzentrum Freiburg - Bad Krozingen, Bad Krozingen, Germany
🇩🇪
Kerckhoff-Klinik gGmbH, Bad Nauheim, Germany

and more 13 locations

Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

Not Applicable

Completed

Conditions: Atrial Septal Defect

Interventions: Device: AMPLATZER Septal Occluder

First Posted Date: 2008-04-02

Last Posted Date: 2019-07-09

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1000

Registration Number: NCT00650936

Locations: 🇺🇸
Jacksonville Pediatric Cardiovascular Center, Jacksonville, Florida, United States
🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States

and more 48 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy